Overview
Amy Early is an Oncologist in Buffalo, New York. Dr. Early is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Hongbin Chen is an Oncologist in Buffalo, New York. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Roswell Park Cancer Institute
Grace Dy is a Hematologist Oncology specialist and a Hematologist in Buffalo, New York. Dr. Dy is rated as an Elite provider by MediFind in the treatment of Thymic Epithelial Tumor. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Early isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Breast CancerDr. Early isDistinguished. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Early isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Early isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Early isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Early isDistinguished. Learn about Lung Cancer.
- Advanced
- AngiosarcomaDr. Early isAdvanced. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Early isAdvanced. Learn about Inflammatory Breast Cancer.
- MesotheliomaDr. Early isAdvanced. Learn about Mesothelioma.
- Experienced
- Adult Soft Tissue SarcomaDr. Early isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Appendix CancerDr. Early isExperienced. Learn about Appendix Cancer.
- Breast Cancer in MenDr. Early isExperienced. Learn about Breast Cancer in Men.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Early isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chromophobe Renal Cell CarcinomaDr. Early isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Early isExperienced. Learn about Clear Cell Sarcoma.